Skip to main content
PMC home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1995;93:203–217.

Progressive hemifacial atrophy. A natural history study.

M T Miller 1, M A Spencer 1
PMCID: PMC1312058  PMID: 8719679

Abstract

PURPOSE: To describe two very different natural history courses in 2 patients with hemifacial atrophy. Progressive hemifacial atrophy (Parry-Romberg syndrome, Romberg syndrome, PHA) is characterized by slowly progressive atrophy, frequently involving only one side of the face, primarily affecting the subcutaneous tissue and fat. The onset usually occurs during the first 2 decades of life. The cause and pathophysiology are unknown. Ophthalmic involvement is common, with progressive enophthalmos a frequent finding. Pupillary disturbances, heterochromia, uveitis, pigmentary disturbances of the ocular fundus, and restrictive strabismus have also been reported. Neurologic findings may be present, but the natural history and progression of ocular findings are often not described in the literature. METHODS: We studied the records and present findings of 2 patients with progressive hemifacial atrophy who were observed in our institution over a 10-year period. RESULTS: Both patients showed progression of ophthalmic findings, primarily on the affected side. One patient has had chronic uveitis with secondary cataract and glaucoma, in addition to retinal pigmentary changes. She also had a third-nerve paresis of the contralateral eye and mild seizure activity. The other patient had mild uveitis, some progression of unilateral retinal pigmentary changes, and a significant increase in hyperopia in the affected eye, in addition to hypotony at age 19 without a clear cause, but with secondary retinal and refractive changes. CONCLUSION: Ocular manifestations of progressive hemifacial atrophy are varied, but can progress from mild visual impairment to blindness.

Full text

PDF

Images in this article

205FIGURE 1
on p.205
206FIGURE 2
on p.206
206FIGURE 3A
on p.206
206FIGURE 3B
on p.206
208FIGURE 4
on p.208
210FIGURE 5
on p.210
211FIGURE 6
on p.211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberer E., Kollegger H., Kristoferitsch W., Stanek G. Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol. 1988 Nov;19(5 Pt 1):820–825. doi: 10.1016/s0190-9622(88)70239-x. [DOI] [PubMed] [Google Scholar]
  2. Aracena T., Roca F. P., Barragan M. Progressive hemifacial atrophy (Parry-Romberg syndrome): report of two cases. Ann Ophthalmol. 1979 Jun;11(6):953–958. [PubMed] [Google Scholar]
  3. Auvinet C., Glacet-Bernard A., Coscas G., Cornelis P., Cadot M., Meyringnac C. Hémiatrophie faciale progressive de Parry-Romberg et sclérodermie localisée. Problèmes nosologiques et pathogéniques. J Fr Ophtalmol. 1989;12(3):169–173. [PubMed] [Google Scholar]
  4. CALMETTES L., AMALRIC P., BESSOU P. [Facial hemiatrophy (Romberg disease) and its ocular manifestations]. Rev Prat. 1959;31:215–241. [PubMed] [Google Scholar]
  5. Collier M. Hemiatrophie faciale progressive avec megalocornee, micropapille, et dystrophie nuageuse centrale de la cornee. Acta Ophthalmol (Copenh) 1971;49(6):946–954. doi: 10.1111/j.1755-3768.1971.tb05946.x. [DOI] [PubMed] [Google Scholar]
  6. FRANCESCHETTI A., KOENIG H. L'importance du facteur hérédo-dégéneratif dans l'hémiatrophie faciale progressive (Romberg); étude des complications oculaires dans ce syndrome. J Genet Hum. 1952 May;1(1):27–64. [PubMed] [Google Scholar]
  7. FRANCESCHETTI A., MAEDER G. Hémiatrophie faciale avec alopécie (syndrome de Romberg) associée à une cyclite hétérochromique (syndrome de Fuchs). J Genet Hum. 1958 Oct;7(3):116–120. [PubMed] [Google Scholar]
  8. Garcher C., Humbert P., Bron A., Chirpaz L., Royer J. Neuropathie optique et syndrome de Parry-Romberg. A propos d'un cas. J Fr Ophtalmol. 1990;13(11-12):557–561. [PubMed] [Google Scholar]
  9. HICKMAN J. W., SHEILS W. S. PROGRESSIVE FACIAL HEMIATROPHY. REPORT OF A CASE WITH MARKED HOMOLATERAL INVOLVEMENT. Arch Intern Med. 1964 May;113:716–720. doi: 10.1001/archinte.1964.00280110096019. [DOI] [PubMed] [Google Scholar]
  10. Hoang-Xuan T., Foster C. S., Jakobiec F. A., Tauber J., Sainz de la Maza M., Krebs W. Romberg's progressive hemifacial atrophy: an association with scleral melting. Cornea. 1991 Jul;10(4):361–366. doi: 10.1097/00003226-199107000-00014. [DOI] [PubMed] [Google Scholar]
  11. Iñigo F., Rojo P., Ysunza A. Aesthetic treatment of Romberg's disease: experience with 35 cases. Br J Plast Surg. 1993 Apr;46(3):194–200. doi: 10.1016/0007-1226(93)90168-b. [DOI] [PubMed] [Google Scholar]
  12. Johnson R. V., Kennedy W. R. Progressive facial hemiatrophy (Parry-Romberg syndrome). Contralateral extraocular muscle impairment. Am J Ophthalmol. 1969 Apr;67(4):561–564. doi: 10.1016/0002-9394(69)94265-2. [DOI] [PubMed] [Google Scholar]
  13. Johnson R. V., Kennedy W. R. Progressive facial hemiatrophy (Parry-Romberg syndrome). Contralateral extraocular muscle impairment. Am J Ophthalmol. 1969 Apr;67(4):561–564. doi: 10.1016/0002-9394(69)94265-2. [DOI] [PubMed] [Google Scholar]
  14. Karny H., Baum J. L. Refractive change as the initial sign of progressive facial hemiatrophy. Am J Ophthalmol. 1975 May;79(5):878–879. doi: 10.1016/0002-9394(75)90750-3. [DOI] [PubMed] [Google Scholar]
  15. Lederman R. J. Progressive facial and cerebral hemiatrophy. Cleve Clin Q. 1984 Fall;51(3):545–548. doi: 10.3949/ccjm.51.3.545. [DOI] [PubMed] [Google Scholar]
  16. Lewkonia R. M., Lowry R. B. Progressive hemifacial atrophy (Parry-Romberg syndrome) report with review of genetics and nosology. Am J Med Genet. 1983 Feb;14(2):385–390. doi: 10.1002/ajmg.1320140220. [DOI] [PubMed] [Google Scholar]
  17. MOSS M. L., CRIKELAIR G. F. Progressive facial hemiatrophy following cervical sympathectomy in the rat. Arch Oral Biol. 1960 Jan;1:254–258. doi: 10.1016/0003-9969(60)90052-2. [DOI] [PubMed] [Google Scholar]
  18. MOURA R. A. Progressive facial hemiatrophia. Report of a case showing ocular and neuro-ophthalmologic changes. Am J Ophthalmol. 1963 Mar;55:635–639. [PubMed] [Google Scholar]
  19. Miller M. T., Sloane H., Goldberg M. F., Grisolano J., Frenkel M., Mafee M. F. Progressive hemifacial atrophy (Parry-Romberg disease). J Pediatr Ophthalmol Strabismus. 1987 Jan-Feb;24(1):27–36. doi: 10.3928/0191-3913-19870101-07. [DOI] [PubMed] [Google Scholar]
  20. Muchnick R. S., Aston S. J., Rees T. D. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol. 1979 Nov;88(5):889–897. doi: 10.1016/0002-9394(79)90567-1. [DOI] [PubMed] [Google Scholar]
  21. Nelhaus G. Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology. 1970 Oct;20(10):965–974. doi: 10.1212/wnl.20.10.965. [DOI] [PubMed] [Google Scholar]
  22. Ong K., Billson F. A., Pathirana D. S., Clifton-Bligh P. A case of progressive hemifacial atrophy with uveitis and retinal vasculitis. Aust N Z J Ophthalmol. 1991 Nov;19(4):295–298. doi: 10.1111/j.1442-9071.1991.tb00675.x. [DOI] [PubMed] [Google Scholar]
  23. PERKINS E. S. Heterochromic uveitis. Trans Ophthalmol Soc U K. 1961;81:53–66. [PubMed] [Google Scholar]
  24. Rees T. D. Facial atrophy. Clin Plast Surg. 1976 Oct;3(4):637–646. [PubMed] [Google Scholar]
  25. SEGAL P., JABLONSKA S., MRZYGLOD S. Ocular changes in linear scleroderma. Am J Ophthalmol. 1961 May;51:807–813. doi: 10.1016/0002-9394(61)91817-7. [DOI] [PubMed] [Google Scholar]
  26. SUGAR H. S., BANKS T. L. FUCHS' HETEROCHROMIC CYCLITIS ASSOCIATED WITH FACIAL HEMIATROPHY (SCLERODERMA EN COUP DE SABRE). Am J Ophthalmol. 1964 Apr;57:627–632. [PubMed] [Google Scholar]
  27. Terstegge K., Kunath B., Felber S., Speciali J. G., Henkes H., Hosten N. MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. AJNR Am J Neuroradiol. 1994 Jan;15(1):145–150. [PMC free article] [PubMed] [Google Scholar]
  28. Tuffanelli D. L., Marmelzat W. L., Dorsey C. S. Linear scleroderma with hemiatrophy: report of three cases associated with collagen-vascular disease. Dermatologica. 1966;132(1):51–58. doi: 10.1159/000254396. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES